
184.14 Delayed Data As of 3:59pm ET | ![]() Today’s Change | 126.95 Today|||52-Week Range 241.48 | -13.31% Year-to-Date |
TRxADE (MEDS) Reports Q4 Loss, Tops Revenue Estimates Mar 27 / Zacks.com - Paid Partner Content |
Previous close | 181.52 |
Today’s open | 185.18 |
Day’s range | 182.55 - 185.56 |
Volume | 4,616 |
Average volume (3 months) | 307,510 |
Market cap | $5.6B |
Earnings growth (last year) | +49.68% |
Earnings growth (this year) | +6.66% |
Earnings growth (next 5 years) | +12.00% |
Revenue growth (last year) | +27.80% |
P/E ratio | 25.3 |
Price/Sales | 4.90 |
Price/Book | 14.61 |
Today’s change | Today’s % change | |
---|---|---|
EXELExelixis Inc | +0.41 | +2.18% |
SYNHSyneos Health Inc | +0.58 | +1.69% |
FGENFibroGen Inc | +0.62 | +3.30% |
CRLCharles River Labora... | +5.61 | +2.92% |
Next reporting date | April 25, 2023 |
EPS forecast (this quarter) | $1.82 |
Annual revenue (last year) | $1.5B |
Annual profit (last year) | $245.2M |
Net profit margin | 16.80% |
Sector Commercial Services |
Industry Miscellaneous Commercial Services |
No executives to display |
Corporate headquarters Cincinnati, Ohio |